116 related articles for article (PubMed ID: 22698703)
1. The effect of PLC-γ2 inhibitors on the growth of human tumour cells.
Feng L; Reynisdóttir I; Reynisson J
Eur J Med Chem; 2012 Aug; 54():463-9. PubMed ID: 22698703
[TBL] [Abstract][Full Text] [Related]
2. Identification of anticancer agents based on the thieno[2,3-b]pyridine and 1H-pyrazole molecular scaffolds.
Eurtivong C; Reynisdóttir I; Kuczma S; Furkert DP; Brimble MA; Reynisson J
Bioorg Med Chem; 2016 Aug; 24(16):3521-6. PubMed ID: 27288184
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and structure-activity relationships of 3,5-diaryl-1H-pyrazoles as inhibitors of arylamine N-acetyltransferase.
Fullam E; Talbot J; Abuhammed A; Westwood I; Davies SG; Russell AJ; Sim E
Bioorg Med Chem Lett; 2013 May; 23(9):2759-64. PubMed ID: 23518278
[TBL] [Abstract][Full Text] [Related]
4. [Effects of blocking phospholipase C-gamma1 signaling pathway on proliferation and apoptosis of human colorectal cancer cell line LoVo].
Liu J; Li M; Cheng BL; Zeng WS; Zou ZP; Luo SQ
Ai Zheng; 2007 Sep; 26(9):957-62. PubMed ID: 17927852
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationship of non-phosphorus-based fructose-1,6-bisphosphatase inhibitors: 2,5-Diphenyl-1,3,4-oxadiazoles.
Liao BR; He HB; Yang LL; Gao LX; Chang L; Tang J; Li JY; Li J; Yang F
Eur J Med Chem; 2014 Aug; 83():15-25. PubMed ID: 24946215
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents.
Zhang XM; Qiu M; Sun J; Zhang YB; Yang YS; Wang XL; Tang JF; Zhu HL
Bioorg Med Chem; 2011 Nov; 19(21):6518-24. PubMed ID: 21962523
[TBL] [Abstract][Full Text] [Related]
7. Thieno[3,2-c]pyrazoles: a novel class of Aurora inhibitors with favorable antitumor activity.
Bindi S; Fancelli D; Alli C; Berta D; Bertrand JA; Cameron AD; Cappella P; Carpinelli P; Cervi G; Croci V; D'Anello M; Forte B; Giorgini ML; Marsiglio A; Moll J; Pesenti E; Pittalà V; Pulici M; Riccardi-Sirtori F; Roletto F; Soncini C; Storici P; Varasi M; Volpi D; Zugnoni P; Vianello P
Bioorg Med Chem; 2010 Oct; 18(19):7113-20. PubMed ID: 20817473
[TBL] [Abstract][Full Text] [Related]
8. 3,5-bis(3'-indolyl)pyrazoles, analogues of marine alkaloid nortopsentin: synthesis and antitumor properties.
Diana P; Carbone A; Barraja P; Martorana A; Gia O; DallaVia L; Cirrincione G
Bioorg Med Chem Lett; 2007 Nov; 17(22):6134-7. PubMed ID: 17911018
[TBL] [Abstract][Full Text] [Related]
9. N-Hydroxyindole-based inhibitors of lactate dehydrogenase against cancer cell proliferation.
Granchi C; Roy S; De Simone A; Salvetti I; Tuccinardi T; Martinelli A; Macchia M; Lanza M; Betti L; Giannaccini G; Lucacchini A; Giovannetti E; Sciarrillo R; Peters GJ; Minutolo F
Eur J Med Chem; 2011 Nov; 46(11):5398-407. PubMed ID: 21944286
[TBL] [Abstract][Full Text] [Related]
10. Pyrazinoindolone inhibitors of MAPKAP-K2.
Goldberg DR; Choi Y; Cogan D; Corson M; DeLeon R; Gao A; Gruenbaum L; Hao MH; Joseph D; Kashem MA; Miller C; Moss N; Netherton MR; Pargellis CP; Pelletier J; Sellati R; Skow D; Torcellini C; Tseng YC; Wang J; Wasti R; Werneburg B; Wu JP; Xiong Z
Bioorg Med Chem Lett; 2008 Feb; 18(3):938-41. PubMed ID: 18221871
[TBL] [Abstract][Full Text] [Related]
11. Locking PDK1 in DFG-out conformation through 2-oxo-indole containing molecules: Another tools to fight glioblastoma.
Sestito S; Daniele S; Nesi G; Zappelli E; Di Maio D; Marinelli L; Digiacomo M; Lapucci A; Martini C; Novellino E; Rapposelli S
Eur J Med Chem; 2016 Aug; 118():47-63. PubMed ID: 27123901
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of N-aryl-5-amino-4-cyanopyrazole derivatives as potent xanthine oxidase inhibitors.
Gupta S; Rodrigues LM; Esteves AP; Oliveira-Campos AM; Nascimento MS; Nazareth N; Cidade H; Neves MP; Fernandes E; Pinto M; Cerqueira NM; Brás N
Eur J Med Chem; 2008 Apr; 43(4):771-80. PubMed ID: 17692432
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, antitumor evaluations and molecular modeling studies of novel 3,5-substituted indolin-2-one derivatives.
Li HH; Zheng XH; Tan JZ; Chen LL; Liu H; Luo XM; Shen X; Lin LP; Chen KX; Ding J; Jiang HL
Acta Pharmacol Sin; 2007 Jan; 28(1):140-52. PubMed ID: 17184594
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, modelling, and antimitotic properties of tricyclic systems characterised by a 2-(5-Phenyl-1H-pyrrol-3-yl)-1,3,4-oxadiazole moiety.
Pinna GA; Murineddu G; Murruzzu C; Zuco V; Zunino F; Cappelletti G; Artali R; Cignarella G; Solano L; Villa S
ChemMedChem; 2009 Jun; 4(6):998-1009. PubMed ID: 19291736
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.
Showalter HD; Sercel AD; Leja BM; Wolfangel CD; Ambroso LA; Elliott WL; Fry DW; Kraker AJ; Howard CT; Lu GH; Moore CW; Nelson JM; Roberts BJ; Vincent PW; Denny WA; Thompson AM
J Med Chem; 1997 Feb; 40(4):413-26. PubMed ID: 9046331
[TBL] [Abstract][Full Text] [Related]
16. A rational approach for the design and synthesis of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitors.
Nepali K; Singh G; Turan A; Agarwal A; Sapra S; Kumar R; Banerjee UC; Verma PK; Satti NK; Gupta MK; Suri OP; Dhar KL
Bioorg Med Chem; 2011 Mar; 19(6):1950-8. PubMed ID: 21353569
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Cdc25 phosphatases by indolyldihydroxyquinones.
Sohn J; Kiburz B; Li Z; Deng L; Safi A; Pirrung MC; Rudolph J
J Med Chem; 2003 Jun; 46(13):2580-8. PubMed ID: 12801222
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of phospholipase C-gamma1 inhibits NGF-induced neuronal differentiation by proliferative activity of SH3 domain.
Nguyen Tle X; Ye K; Cho SW; Ahn JY
Int J Biochem Cell Biol; 2007; 39(11):2083-92. PubMed ID: 17618160
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of a selective radioligand for ELOVL6.
Shimamura K; Takahashi H; Kitazawa H; Miyamoto Y; Nagumo A; Tang C; Dean D; Nagase T; Sato N; Tokita S
J Biochem; 2009 Sep; 146(3):429-37. PubMed ID: 19505953
[TBL] [Abstract][Full Text] [Related]
20. New diarylureas and diarylamides containing 1,3,4-triarylpyrazole scaffold: Synthesis, antiproliferative evaluation against melanoma cell lines, ERK kinase inhibition, and molecular docking studies.
Choi WK; El-Gamal MI; Choi HS; Baek D; Oh CH
Eur J Med Chem; 2011 Dec; 46(12):5754-62. PubMed ID: 22014559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
